Osteomesh Series - Bone matrix implant, synthetic

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

MAH:

Osteopore Australasia Pty Ltd

class:

Class III

manufactured_by:

Osteopore International Pte Ltd 2 Tukang Innovation Grove, 09-06 MedTech Hub, Singapore, 618305 Singapore

therapeutic_area:

17751 - Bone matrix implant, synthetic

therapeutic_indication:

Osteomesh is a sterile mesh scaffold bone void filler used to fill cranial defects. It is rectangular in shape. It conforms to the shape of the defect thus maximising direct contact with the viable bone host. It is made of polycaprolactone which degrades and resorbs fully in vivo by hydrolysis, then is metabolised by the body. This will occur over a period of 18-24 months. Osteomesh? is a bone void filler. It is indicated for the repair of orbital floor fractures. The shape of the Osteomesh conforms to the defect, thus maximising direct contact with the viable bone host.

authorization_status:

A

authorization_date:

2020-04-15